3 November 2022
3 November 2022 Q3 Highlights1,2 · Q3 revenue of $1,250 million (2021: $1,266 million), representing underlying revenue growth of 4.8% (600bps FX headwind resulted in…
Issued: 3 November 2022, London UK EAGLE-2 and EAGLE-3 phase III trials for gepotidacin stopped early for efficacy following pre-planned interim analysis by Independent…
2 November 2022
THWAITES (DANIEL) PLC – Half-year Report PR Newswire INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2022 CHAIRMAN’S STATEMENT OVERVIEW The Company has turned…
Issued: Wednesday, 2 November 2022, London U.K. GSK delivers strong Q3 2022 sales of £7.8 billion +18% AER, +9% CER and Total EPS 255.9p…
Hiscox Ltd trading statement Hamilton, Bermuda (2 November 2022) – Hiscox Ltd (LSE:HSX), the international specialist insurer, today issues its trading statement for the first…
GSK’s respiratory syncytial virus older adult vaccine candidate granted Priority Review by US FDA â— US FDA has set a Prescription Drug User Fee…
Trading Statement – 2 November 2022 HEADLINES · In the thirteen weeks to 29 October full price sales 1 were up +0.4% 2 versus last year. This was slightly ahead of…
1 November 2022
1 November 2022 INTERNATIONAL BIOTECHNOLOGY TRUST PLC (“IBT” or the “Company”) Annual Report for the year ended 31 August 2022 WHO WE ARE International…